Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome

NCT03031821 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

168

Enrollment

OTHER

Sponsor class

Stopped Manufacturer discontinued the production of study drugs.

Conditions

Prostate Cancer
Metabolic Syndrome

Interventions

DRUG: Metformin
DRUG: Placebo Oral Tablet

Sponsor

Canadian Urologic Oncology Group

Collaborators

[object Object]
[object Object]
[object Object]